HILT in Greater Trochanteric Pain Syndrome

NCT07749066 · tracked via the Priya Life Science Turkey tracker

Sponsor

Ankara Etlik City Hospital

Phase

Not applicable

Started

2026-06-01

Last updated

2026-08-06

Condition(s) studied

Greater Trochanteric Pain Syndrome

Investigational drug(s) / intervention(s)

High-Intensity Laser Therapy (HILT)Sham Laser

High-Intensity Laser Therapy (HILT): High-intensity laser therapy will be applied to the trochanteric region using a pulsed Nd:YAG laser device over 10 sessions (5 sessions per week for 2 consecutive weeks). Treatments will be delivered by an experienced physiotherapist using a standardized protocol and consistent application technique. Total energy per session will be standardized. Participants will also perform a structured home exercise program focusing on hip muscle activation and flexibility.

Sham Laser: A sham laser intervention will be applied using the same device and treatment setup without delivering therapeutic laser energy. The number and frequency of sessions will be identical to the active treatment group to ensure blinding. Participants will also perform the same structured home exercise program as the intervention group.

Study summary

Greater Trochanteric Pain Syndrome (GTPS) is a common cause of lateral hip pain that can significantly impair daily activities and quality of life. Conservative treatments, including physical therapy modalities and injections, are considered first-line management.

High-Intensity Laser Therapy (HILT) is a non-invasive modality with greater tissue penetration compared to low-level laser therapy and has shown promising results in musculoskeletal disorders; however, evidence in GTPS is limited.

This study aims to evaluate the efficacy of HILT compared with a sham intervention in patients with GTPS, focusing on pain intensity, functional status, and quality of life.

Eligibility

Sex

ALL

Min age

18 Years

Max age

80 Years

Healthy volunteers

Inclusion Criteria: * Adults aged 18 to 80 years * Patients diagnosed with Greater Trochanteric Pain Syndrome (GTPS) based on clinical examination * Presence of symptoms for at least 3 months * Pain intensity ≥4 on the Visual Analog Scale (VAS) * No corticosteroid injection or other conservative treatment within the last 3 months Exclusion Criteria: * Hip fracture, tumor, infection, or advanced osteoarthritis * Contraindications to high-intensity laser therapy (e.g., pacemaker, pregnancy, coagulation disorders, anticoagulant therapy, neoplasia, history of epilepsy) * Contraindications to physical activity (e.g., ischemic heart disease, arrhythmia, uncontrolled hypertension, heart failure, severe respiratory insufficiency) * Peripheral vascular disorders (e.g., thrombophlebitis, thrombosis, lymphedema) * History of trauma within the last 3 months or prior surgery involving the lower extremity or lumbar spine * Neurological disorders or chronic inflammatory diseases

Primary outcome measure(s)

Pain Intensity (Visual Analog Scale, VAS) — Baseline (T0), 2 weeks (end of the treatment period; T1), and 8 weeks after treatment completion (T2).
Pain intensity will be assessed using a 0-10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates worst imaginable pain.

Trial sites (1)

Facility	City	Region	Status
Etlik City Hospital	Ankara	Yenimahalle	Recruiting

More Ankara Etlik City Hospital trials in Turkey

Laparoscopic Appendectomy: Outcomes of 10 mmHg Versus 15 mmHg Intra-abdominal Pressure Starting soon

"The Effect of Adductor Canal Block Performed With Postoperative Thigh Tourniquet Application on Pain After Total Knee Arthroplasty" Enrolling by invitation

Perfusion Index for Predicting Diabetic Ketoacidosis Severity in the Emergency Department Recruiting

Effectiveness of Theta Burst Stimulation For Upper and Lower Extremity Recovery in Stroke Recruiting

45 V vs 60 V Pulsed Radiofrequency of the Cervical Dorsal Root Ganglion for Cervical Radicular Pain Recruiting

Other trials for the same condition

ESWT vs Conventional Physical Therapy in Greater Trochanteric Pain Syndrome Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07749066 on ClinicalTrials.gov ↗ ← All trials in Turkey